NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a targeted pill boost lymphoma cure rates?
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug acalabrutinib to standard chemotherapy and rituximab can improve cure rates for people with untreated diffuse large B-cell lymphoma, the most common type of non-Hodgkin lymphoma. About 132 adults with aggressive B-cell lymphom…
Matched conditions: NHL
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a liposomal chemo combo improve First-Line lymphoma treatment?
Disease control Recruiting nowResearchers are testing a chemotherapy regimen called CMOP±R in adults newly diagnosed with non-Hodgkin's lymphoma. The regimen combines liposomal mitoxantrone with cyclophosphamide, vincristine, prednisone, and optional rituximab, given in four-week cycles. The study aims to mea…
Matched conditions: NHL
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill hopes to tackle tough lymphoma
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug, HSK47977, in 110 adults with relapsed or refractory Non-Hodgkin's lymphoma. The study has two parts: first, finding the safest dose, then expanding to see how well it works. Participants must have measurable tumors and adequ…
Matched conditions: NHL
Phase 1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Yoga and mindfulness may help cancer survivors heal from within
Symptom relief Recruiting nowThis study tests whether yoga and mindfulness programs can improve quality of life, reduce inflammation, and even affect gene activity in people who have survived lung, colon, or non-Hodgkin's lymphoma cancer. One hundred survivors, at least six months past treatment, will be ran…
Matched conditions: NHL
Sponsor: Barbara Nemesure • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC